✦ LIBER ✦

Effects of pretreatment with spironolactone on pharmacokinetics of 4‴-methyldigoxin in man

✍ Scribed by U. Abshagen; H. Rennekamp; J. Kuhlmann

Book ID: 112349098
Publisher: Springer-Verlag
Year: 1976
Tongue: English
Weight: 547 KB
Volume: 292
Category: Article
ISSN: 0028-1298
DOI: 10.1007/bf00506494

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of pretreatment with spironolact

Effects of pretreatment with spironolactone on pharmacokinetics of 4‴-methyldigoxin in rats

✍ Ulrich Abshagen 📂 Article 📅 1973 🏛 Springer-Verlag 🌐 English ⚖ 544 KB

Pharmacokinetic behaviour of 4‴-methyldi

Pharmacokinetic behaviour of 4‴-methyldigoxin in man

✍ H. Rennekamp; Ch. Rennekamp; U. Abshagen; K. v. Bergmann; N. Rietbrock 📂 Article 📅 1972 🏛 Springer-Verlag 🌐 English ⚖ 170 KB

Effect of enterohepatic circulation on t

Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man

✍ U. Abshagen; U. Grodzicki; U. Hirschberger; H. Rennekamp 📂 Article 📅 1977 🏛 Springer-Verlag 🌐 English ⚖ 800 KB

Influence of spironolactone pretreatment

Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats

✍ H. -F. Vöhringer; L. Weller; N. Rietbrock 📂 Article 📅 1975 🏛 Springer-Verlag 🌐 English ⚖ 570 KB

Evaluation of cardiac activity and pharm

Evaluation of cardiac activity and pharmacokinetic analysis of3H-adriamycin in patients pretreated with beta-methyldigoxin

✍ G. Fronzo; A. Bertuzzi; E. Ronchi; F. P. Villani; L. Ronchetti 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 345 KB

Fluoxetine pretreatment effects pharmaco

Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat

✍ Vijay V. Upreti; Natalie D. Eddington 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

Fluoxetine has been shown to provide protection from MDMA induced long term neurotoxicity. The purpose of this investigation is to evaluate the pharmacokinetic drug interaction between MDMA and fluoxetine and also to determine the role of P-glycoprotein (P-gp) on mediating drug-drug interactions wit